Paralel Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
8,536
+3,431
+67% +$1.27M 0.14% 29
2026
Q1
$1.38M Hold
5,105
0.06% 95
2025
Q4
$1.69M Hold
5,105
0.07% 91
2025
Q3
$1.76M Buy
5,105
+3
+0.1% +$907 0.07% 89
2025
Q2
$1.59M Buy
5,102
+23
+0.5% +$8.79K 0.06% 95
2025
Q1
$2.66M Hold
5,079
0.11% 52
2024
Q4
$2.57M Buy
5,079
+464
+10% +$264K 0.11% 56
2024
Q3
$2.7M Hold
4,615
0.12% 40
2024
Q2
$2.35M Buy
4,615
+568
+14% +$278K 0.11% 42
2024
Q1
$2M Hold
4,047
0.09% 72
2023
Q4
$2.13M Hold
4,047
0.11% 60
2023
Q3
$2.04M Buy
4,047
+44
+1% +$21.7K 0.11% 43
2023
Q2
$1.92M Buy
4,003
+445
+13% +$218K 0.1% 58
2023
Q1
$1.68M Buy
3,558
+94
+3% +$45.4K 0.09% 57
2022
Q4
$1.84M Buy
+3,464
New +$1.83M 0.11% 40

Other funds holding UNH

Paralel Advisors's UNH Position: Q2 2026 in Review

Paralel Advisors increased its UnitedHealth (UNH) stake by 67% in Q2 2026, buying an estimated $1.27M and bringing the position to 8,536 shares worth $3.55M. The position accounts for 0.14% of the portfolio, ranked #29.

Paralel Advisors first reported a position in UNH in Q4 2022 and has held it in 15 quarters since. 3,378 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Paralel Advisors held 8,536 shares of UnitedHealth worth $3.55M as of Q2 2026.
  • Paralel Advisors bought 3,431 UnitedHealth shares in Q2 2026, an estimated $1.27M.
  • UnitedHealth made up 0.14% of Paralel Advisors's portfolio in Q2 2026, its #29 holding.
  • Paralel Advisors first reported a position in UnitedHealth in Q4 2022 and has held it in 15 quarters since.
  • 3,378 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.